Original Research
Accepted on 01 Jul 2025
Global Research Trends in Surgical Management of Choledochal Cysts：a bibliometric analysis from 2000 to 2024
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1611045
Type at least 3 characters
249 articles
Original Research
Accepted on 30 Jun 2025
Profiles of self-efficacy among cirrhotic patients in northern Guizhou Province, China: a latent profile analysis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1627132
Case Report
Accepted on 27 Jun 2025
A patient with acute hepatitis E and intractable vomiting: A case report
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1614921
- 113 views
Original Research
Accepted on 27 Jun 2025
Advancements and trends in digestive system autotransplantation: a bibliometric and visualization analysis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1537446
Original Research
Published on 25 Jun 2025
Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15–49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1568211
- 403 views
Review
Published on 25 Jun 2025
Mapping and visualization of global research progress on autophagy in metabolic dysfunction-associated steatotic liver disease and metabolic syndrome: a bibliometric analysis (2009–2024)
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1525526
- 303 views
Review
Published on 25 Jun 2025
Advances in research on the role of gut microbiota in the pathogenesis and precision management of gallstone disease
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1535355
- 302 views
Original Research
Published on 25 Jun 2025
Association between red cell distribution width-to-albumin ratio and all-cause mortality in critically ill cirrhotic patients with sepsis: a retrospective analysis of the MIMIC-IV database
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1610726
- 240 views
Editorial
Published on 24 Jun 2025
Editorial: Chronic hepatitis B management: current status and future directions
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1638241
- 309 views
Original Research
Accepted on 23 Jun 2025
An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1605024
Original Research
Accepted on 23 Jun 2025
Temporal trends in the incidence and mortality of gallbladder and biliary diseases in mainland China: past trends and future prediction
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1599134
- 124 views
Original Research
Accepted on 20 Jun 2025
Evaluation of the protective effect of paeoniflorin on alcoholic liver damage and its effect on intestinal flora
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1620367
Original Research
Accepted on 19 Jun 2025
Associations of estimated glucose disposal rate with risk of futureincident metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1589245
- 125 views
Case Report
Accepted on 19 Jun 2025
Case report: Transjugular intrahepatic portosystemic shunt combined with hemodialysis for refractory ascites treatment in a patient with idiopathic non-cirrhotic portal hypertension and uremia
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1607521
- 114 views
Original Research
Accepted on 18 Jun 2025
48-week prognostic analysis of patients with very low-level viremia in hepatitis B cirrhosis: A single-center retrospective study
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1549791
- 131 views
Original Research
Published on 18 Jun 2025
Efficacy of various sequences of transcatheter arterial chemoembolization combined with PD-1 inhibitors in advanced hepatocellular carcinoma: a retrospective analysis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1574295
- 222 views